171
Views
8
CrossRef citations to date
0
Altmetric
Cornea

Long-Term Outcome of Corneal Collagen Crosslinking with Riboflavin and UV-A Irradiation for Keratoconus*

, , , , &
Pages 1472-1478 | Received 05 May 2022, Accepted 15 Aug 2022, Published online: 29 Sep 2022

References

  • Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42(4):297–319. doi:10.1016/S0039-6257(97)00119-7.
  • Buhren J, Bischoff G, Kohnen T. Keratoconus: clinical aspects, diagnosis, therapeutic possibilities. Klin Monbl Augenheilkd. 2011;228(10):923–940. doi:10.1055/s-0031-1280224.
  • Wilson A, Jones J, Marshall J. Biomechanical evaluation of decellularized and crosslinked corneal implants manufactured from porcine corneas as a treatment option for advanced keratoconus. Front Bioeng Biotechnol. 2022;10:862969.
  • Spoerl E, Huhle M, Seiler T. Induction of CROSS-LINKS IN CORNEAL TISSUE. Exp Eye Res. 1998;66(1):97–103. doi:10.1006/exer.1997.0410.
  • Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. Part II. Clinical indications and results. Ocul Surf. 2013;11(2):93–108. doi:10.1016/j.jtos.2013.01.003.
  • Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf. 2013;11(2):65–74. doi:10.1016/j.jtos.2013.01.002.
  • Spörl E, Raiskup-Wolf F, Pillunat LE. Biophysical principles of collagen cross-linking. Klin Monbl Augenheilkd. 2008;225(2):131–137.
  • Randleman JB, Khandelwal SS, Hafezi F. Corneal cross-linking. Surv Ophthalmol. 2015;60(6):509–523. doi:10.1016/j.survophthal.2015.04.002.
  • Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi:10.1016/S0002-9394(02)02220-1.
  • Wollensak G, Spörl E, Seiler T. Treatment of keratoconus by collagen cross linking. Ophthalmologe. 2003;100(1):44–49. doi:10.1007/s00347-002-0700-3.
  • Medeiros CS, Giacomin NT, Bueno RL, Ghanem RC, Moraes HV, Santhiago MR, Jr. Accelerated corneal collagen crosslinking: technique, efficacy, safety, and applications. J Cataract Refract Surg. 2016;42(12):1826–1835. doi:10.1016/j.jcrs.2016.11.028.
  • Shajari M, Kolb CM, Agha B, Steinwender G, Müller M, Herrmann E, Schmack I, Mayer WJ, Kohnen T. Comparison of standard and accelerated corneal cross-linking for the treatment of keratoconus: a meta-analysis. Acta Ophthalmol. 2019;97(1):e22–e35. doi:10.1111/aos.13814.
  • Ng SM, Hawkins BS, Kuo IC. Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus: findings from a cochrane systematic review. Am J Ophthalmol. 2021;229:274–287. doi:10.1016/j.ajo.2021.05.009.
  • Hoyer A, Raiskup-Wolf F, Sporl E, Pillunat LE. Collagen cross-linking with riboflavin and UVA light in keratoconus. Results from Dresden. Ophthalmologe. 2009;106(2):133–140. doi:10.1007/s00347-008-1783-2.
  • Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Denaro R. Age-related long-term functional results after riboflavin UV A corneal cross-linking. J Ophthalmol. 2011;2011:608041. doi:10.1155/2011/608041.
  • Caporossi A, Mazzotta C, Baiocchi S, Caporossi T. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149(4):585–593. doi:10.1016/j.ajo.2009.10.021.
  • Theuring A, Spoerl E, Pillunat LE, Raiskup F. Corneal collagen cross-linking with riboflavin and ultraviolet-A light in progressive keratoconus. Results after 10-year follow-up. Ophthalmologe. 2015;112(2):140–147. doi:10.1007/s00347-014-3114-0.
  • Nicula C, Pop R, Rednik A, Nicula D. 10-Year results of standard cross-linking in patients with progressive keratoconus in Romania. J Ophthalmol. 2019;2019:1–5. doi:10.1155/2019/8285649.
  • Raiskup F, Theuring A, Pillunat LE, Spoerl E. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg. 2015;41(1):41–46. doi:10.1016/j.jcrs.2014.09.033.
  • Vinciguerra R, Pagano L, Borgia A, Montericcio A, Legrottaglie EF, Piscopo R, Rosetta P, Vinciguerra P. Corneal cross-linking for progressive keratoconus: up to 13 years of follow-up. J Refract Surg. 2020;36(12):838–843. doi:10.3928/1081597X-20201021-01.
  • O'Brart DP, Patel P, Lascaratos G, Wagh VK, Tam C, Lee J, O'Brart NA. Corneal cross-linking to halt the progression of keratoconus and corneal ectasia: seven-year follow-up. Am J Ophthalmol. 2015;160(6):1154–1163. doi:10.1016/j.ajo.2015.08.023.
  • Wittig-Silva C, Chan E, Islam FM, Wu T, Whiting M, Snibson GR. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results. Ophthalmology. 2014;121(4):812–821. doi:10.1016/j.ophtha.2013.10.028.
  • Konrad EM, Röck D, Blumenstock G, Bartz-Schmidt KU, Röck T. Langzeiterfahrungen des kornealen Crosslinkings bei Patienten mit progredientem Keratokonus an der Universitäts-Augenklinik Tübingen. Der Ophthalmologe. 2020;117(6):538–545. doi:10.1007/s00347-019-00982-w.
  • Tuft SJ, Moodaley LC, Gregory WM, Davison CR, Buckley RJ. Prognostic factors for the progression of keratoconus. Ophthalmology. 1994;101(3):439–447. doi:10.1016/S0161-6420(94)31313-3.
  • Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358–1362. doi:10.1016/j.jcrs.2009.03.035.
  • Lenk J, Herber R, Oswald C, Spoerl E, Pillunat LE, Raiskup F. Risk factors for progression of keratoconus and failure rate after corneal cross-linking. j Refract Surg. 2021;37(12):816–823. doi:10.3928/1081597X-20210830-01.
  • Spoerl E, Raiskup-Wolf F, Kuhlisch E, Pillunat LE. Cigarette smoking is negatively associated with keratoconus. J Refract Surg. 2008;24(7):737–740.
  • Seifert FK, Theuersbacher J, Schwabe D, Lamm O, Hillenkamp J, Kampik D. Long-term outcome of corneal collagen crosslinking with riboflavin and UV-A irradiation for keratoconus. medRxiv. 2022; doi:10.1101/2022.02.05.22270507.
  • Seifert FK. Dissertation, “Kollagen-Crosslinking der Hornhaut mit UV-A und Riboflavin zur Behandlung des Keratokonus – 10 Jahres Ergebnisse” Julius-Maximilians-University Wuerzburg. Available from: https://opus.bibliothek.uni-wuerzburg.de (doi will be available in September 2022).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.